MARY BIRD PERKINS CANCER CENTER (EIN 237010520) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1968

Legal Domicile

Principal Officer

JONAS FONTENOT PHD

Phone

2252151223

Tax Period

2023-07-01 to 2024-06-30

MARY BIRD PERKINS CANCER CENTER, founded in 1968, is a major nonprofit in the Diseases & Disorders sector that reported $229.6M in total revenue in fiscal year 2023. Revenue surged 35% from the prior year, signaling strong growth momentum.

Mission

TO IMPROVE SURVIVORSHIP AND LESSEN THE BURDEN OF CANCER THROUGH EXPERT TREATMENT, COMPASSIONATE CARE, EARLY DETECTION, RESEARCH, AND EDUCATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $6,694,545

Program Service Revenue $190,653,294

Investment Income $920,880

Other Revenue $31,303,842

TOTAL REVENUE $229,572,561

Expense Breakdown

Grants Paid $0

Salaries & Benefits $45,392,015

Fundraising Expenses $0

Program Expenses $195,760,280

Other Expenses $189,094,627

TOTAL EXPENSES $234,486,642

Year-over-Year Comparison

	2023	2022	Change
Revenue	$229,572,561	$169,638,286	+0.4%
Expenses	$234,486,642	$172,236,206	+0.4%
Net Income	$-4,914,081	$-2,597,920	+0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

378

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,830,918

Total Directors

$642,548

Key Employees

$493,458

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JONAS FONTENOT	PRESIDENT/CEO	40.00	Officer Director	$552,655	$89,893	$642,548
HANK SAURAGE	VICE CHAIR	1.00	Officer Director	$0	$0	$0
TOM ADAMEK	DIRECTOR	1.00	Director	$0	$0	$0
KATE CASTLE MD	DIRECTOR	1.00	Director	$0	$0	$0
CYNTHIA PETERSON	DIRECTOR	1.00	Director	$0	$0	$0
ANTHONY O'CONNOR	DIRECTOR	1.00	Director	$0	$0	$0
NATHANIEL TANNEHILL	DIRECTOR	1.00	Director	$0	$0	$0
CATHY GIERING	DIRECTOR	1.00	Director	$0	$0	$0
TEE BROWN	DIRECTOR	1.00	Director	$0	$0	$0
CORDELL HAYMON	CHAIR	1.00	Officer Director	$0	$0	$0
STEVEN MOORE	DIRECTOR	1.00	Director	$0	$0	$0
SANDRA BROWN	DIRECTOR	1.00	Director	$0	$0	$0
GERALD T GOSS	SECRETARY/TREASURER	1.00	Officer Director	$0	$0	$0
JOHN BOYCE	DIRECTOR	1.00	Director	$0	$0	$0
MAWE TAKYI	DIRECTOR	1.00	Director	$0	$0	$0
KYLE FRANCE	DIRECTOR	1.00	Director	$0	$0	$0
VANESSA GRAHAM	DIRECTOR	1.00	Director	$0	$0	$0
MARK DEARMAN	DIRECTOR	1.00	Director	$0	$0	$0
REBECCA NELSON	DIRECTOR	1.00	Director	$0	$0	$0
MATT MULLINS	DIRECTOR	1.00	Director	$0	$0	$0
TODD D STEVENS	CHIEF STRATEGY OFFICER	40.00	Officer	$1,090,817	$97,553	$1,188,370
DANA NEUCERE	CFO/VP OF FINANCE	40.00	Officer	$0	$0	$0
JOCELYN AUSTIN-DUFFIN	VP OF CANCER SUPPORT & OUT	40.00	Key Emp	$214,240	$43,480	$257,720
DANIELLE MACK	VP OF DEVELOPMENT	1.00	Key Emp	$223,669	$12,069	$235,738
DIVYANG MEHTA MD	RADIATION ONCOLOGIST	40.00	Highest	$487,284	$45,890	$533,174
VICTOR LIN	MEDICAL DIRECTOR	40.00	Highest	$421,068	$28,068	$449,136
SOTIRIOS STATHAKIS	CHIEF, CLINICAL PHYSICS	40.00	Highest	$334,153	$45,665	$379,818
ANDRE BONNECAZE	MEDICAL DOCTOR	40.00	Highest	$345,403	$48,876	$394,279

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$229,572,561	$234,486,642	$141,086,814	$-4,914,081
2023	$169,638,286	$172,236,206	$147,413,331	$-2,597,920
2022	$112,882,708	$112,723,138	$130,131,075	$159,570
2021	$42,685,291	$40,579,316	$85,168,011	$2,105,975
2020	$38,410,274	$39,962,673	$90,678,562	$-1,552,399
2019	$35,311,618	$36,227,520	$86,007,004	$-915,902
2018	$35,263,212	$35,309,876	$87,923,295	$-46,664

MARY BIRD PERKINS CANCER CENTER